Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture

Orthopedics

Volumn 35, Issue 6, 2012, Pages

  Fowler, John R ^a   Criner, Katharine ^a   Craig, Matthew R ^a,b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ENOXAPARIN;

ACCIDENT PREVENTION; AGED; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG SAFETY; FEMALE; FEMUR SUBTROCHANTERIC FRACTURE; FOLLOW UP; HIP RADIOGRAPHY; HUMAN; INTRAMEDULLARY NAILING; JOINT MOBILITY; LEG PAIN; LOWER ABDOMINAL PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; OUTCOME ASSESSMENT; PELVIS RADIOGRAPHY; POSTOPERATIVE CARE; PROPHYLAXIS; RISK BENEFIT ANALYSIS; STRESS FRACTURE; THROMBOSIS PREVENTION; TREATMENT PLANNING; WEIGHT BEARING;

AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURES, STRESS; HUMANS; OSTEOPOROSIS; TREATMENT OUTCOME;

EID: 84864686050     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120525-41     Document Type: Article

References (19)

1. Rodan GA, Reszka AA. Osteoporosis and bisphosphonates. J Bone Joint Surg Am. 2003; 85(suppl 3):8-12. (Pubitemid 36951112)
2. Morris CD, Einhorn TA. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am. 2005; 87(7):1609-1618. (Pubitemid 40917766)
3. Gates BJ, Sonnett TE, Duvall CA, Dobbins EK. Review of osteoporosis pharmacotherapy for geriatric patients. Am J Geriatr Pharmacother. 2009; 7(6):293-323.
4. Hodsman AB, Hanley DA, Josse R. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. CMAJ. 2002; 166(11):1426-1430. (Pubitemid 34539362)
5. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. fracture intervention trial research group. Lancet. 1996; 348(9041):1535-1541. (Pubitemid 26411651)
6. Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008; (1):CD001155.
7. Capeci CM, Tejwani NC. Bilateral lowenergy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009; 91(11):2556-2561.
8. Cheung RK, Leung KK, Lee KC, Chow TC. Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007; 13(6):485-489. (Pubitemid 351206686)
9. Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007; 89(3):349-353. (Pubitemid 46563912)
10. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008; 39(2):224-231.
11. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008; 358(12):1304-1306. (Pubitemid 351439247)
12. Lenart BA, Neviaser AS, Lyman S, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009; 20(8):1353-1362.
13. Neviaser AS, Lane JM, Lenart BA, Edobor- Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008; 22(5):346-350. (Pubitemid 351630250)
14. Sayed-Noor AS, Sjoden GO. Case reports: Two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res. 2009; 467(7):1921-1926.
15. Black DM, Kelly MP, Genant HK, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010; 362(19):1761-1771.
16. Fowler JR, Craig MR. Association of lowenergy femoral shaft fractures and bisphosphonate use. Orthopedics. 2012; 35(1):e38-e40.
17. Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a registerbased national cohort study. J Bone Miner Research. 2009; 24(6):1095-1102.
18. Giusti A, Hamdy NAT, Papapoulos SE. Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case/ case series studies. Bone. 2010; 47(2):169-180.
19. Banffy MB, Vrahas MS, Ready JE, Abraham JA. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures. Clin Orthop Relat Res. 2011:1-7.